(Reuters) -Shares of U.S. drugmakers rebounded on Monday after an initial selloff as analysts said that President Donald ...

US President Donald Trump signed an executive order requiring drugmakers to lower prices, aligning with international rates.

A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...

Current health news covers major investments by Merck Animal Health and Gilead Sciences in the U.S., regulatory decisions ...

President Trump signed an executive order aimed at lowering U.S. drug prices to match those of other countries, prompting ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Global pharmaceutical shares jumped in intraday trading Monday, reversing their pre-market declines, as investors anticipated ...

The president said his executive order will require pharmaceutical companies to price drugs in the U.S. in line with the ...

President Donald Trump will sign an executive order Monday to link the cost of drugs to prices abroad, under a so-called ...

President Donald Trump signed a wide-reaching executive order on Monday directing drugmakers to lower the prices of their ...

US President Donald Trump said Monday he would slash drug prices so they match those abroad, accusing Europe in particular of ...